Biotech · Private company
WindMIL Therapeutics
Track this companyFree. Adds WindMIL Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MILs™ - NSCLCPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- nivolumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- tadalafilPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell CarcinomaNA · TERMINATED · started Jul 22, 2020ClinicalTrials.gov NCT04341740 · fetched Nov 12, 2026
- Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCPHASE2 · TERMINATED · started Oct 15, 2019ClinicalTrials.gov NCT04069936 · fetched Nov 12, 2026